December 10, 2024

Minebea Mitsumi Inc.

Announcement of individual stocks regarding the completion of the business transfer by the company's consolidated subsidiary.

As announced in the "Announcement regarding the acquisition of business by our consolidated subsidiary" dated September 20, 2024, our consolidated subsidiary, Abrick Co., Ltd. (hereinafter referred to as "Abrick"), has decided to acquire the medical-related business operated by Socionext Inc. (hereinafter referred to as "Socionext") (hereinafter referred to as "this business acquisition"). Today, we would like to inform you that this business acquisition has been completed.

1. Purpose of this transaction and future operational policy

We position our core business, the "Eight Spears," as a product that can leverage our strengths in ultra-precision processing technology and mass production technology, and that is easy to become an essential part of our customers' business. We will provide new value to our customers by combining these strengths.
Abic Corporation started its analog semiconductor business in 1968 with the development of the first mass-produced CMOS IC for quartz watch, and has since been using advanced analog technology to develop products that achieve small size and low power consumption. It plays an important role in one of the "Eight Spears," the analog semiconductor business, and has been providing customers with high-precision analog and mixed-signal semiconductors in fields such as automotive, medical devices, industrial equipment, and consumer devices.
In particular, the medical device IC acquired from Hitachi, Ltd. in 2016 is one of Abic's focused businesses and has steadily grown as a key product for ultrasound diagnostic devices, including the transmission IC, which is a key device, and the high-voltage switch IC.

In this target business, we develop and sell solutions (LSI/board modules/equipment) for handheld ultrasound diagnostic devices in the healthcare and medical device fields. Our solutions are characterized by wireless, low power consumption, small size and light weight, and high image quality. The source of competitive advantage in this target business lies in the deep knowledge of systems, including firmware, and receiving technology, including high-definition image generation, in addition to LSI.
This acquisition creates a complementary relationship between the transmission technology that Averyk has excelled in and the reception technology strengths of the target business, enabling the development and market introduction of even higher value-added products. As a result, further market share expansion in the ultrasound diagnostic system market will be pursued, particularly aiming for industry leadership in the rapidly growing handheld ultrasound diagnostic system market.
With this business acquisition, we will create significant synergy effects and ensure the achievement of our target revenue of 200 billion yen for the entire analog semiconductor business for the fiscal year ending in March 2029.

* "Sogo" means "comprehensive" as well as "matching" or "bringing together." In this context, it means to combine and utilize our in-house technologies to evolve our core products and create new products in various fields by further matching these evolved products.

2. Overview of the business acquisition

(1) Content of the acquired business

Medical-related business operated by Socionext
(Mainly the development, manufacturing, and sales business of ultrasound diagnostic devices and LSI.)

(2) Items of Assets and Liabilities of the Acquired Division.

Inventories, products, tangible and intangible fixed assets related to this business
(Cash and deposits, as well as monetary receivables and liabilities not listed above, are excluded)

3. Future Outlook.

The impact on our consolidated performance for the fiscal year ending March 2025 from this business acquisition is minimal. In the event that new disclosure matters arise, they will be disclosed promptly as soon as they are identified.

That's all.

Return to the list of press releases.

This is the end of the main text.

Tweet.